To determine whether loss of imprinting in cancer might be reversed by
altering DNA methylation, we treated tumor cells with 5-aza-2'-deoxyc
ytidine, a specific inhibitor of cytosine DNA methyltransferase, Treat
ed cells showed several significant and reproducible changes, (a) Equa
l expression of maternal and paternal alleles of insulin-like growth f
actor 2 switched to predominant expression of a single parental allele
, (b) H19 expression was reactivated, (c) Biallelic H19 expression swi
tched La mono-allelic expression, (d) Biallelic methylation of H19 swi
tched to preferential allelic methylation, These results imply that ab
normally imprinted cells susceptible to epigenetic modification and th
at the effect of 5-aza-2'-deoxycytidine on tumor cells with Boss of im
printing is not random hut specific to one allele.